Literature DB >> 30109749

The nuclear receptor superfamily: A structural perspective.

Emily R Weikum1, Xu Liu1, Eric A Ortlund1.   

Abstract

Nuclear receptors (NRs) are a family of transcription factors that regulate numerous physiological processes such as metabolism, reproduction, inflammation, as well as the circadian rhythm. NRs sense changes in lipid metabolite levels to drive differential gene expression, producing distinct physiologic effects. This is an allosteric process whereby binding a cognate ligand and specific DNA sequences drives the recruitment of diverse transcriptional co-regulators at chromatin and ultimately transactivation or transrepression of target genes. Dysregulation of NR signaling leads to various malignances, metabolic disorders, and inflammatory disease. Given their important role in physiology and ability to respond to small lipophilic ligands, NRs have emerged as valuable therapeutic targets. Here, we summarize and discuss the recent progress on understanding the complex mechanism of action of NRs, primarily from a structural perspective. Finally, we suggest future studies to improve our understanding of NR signaling and better design drugs by integrating multiple structural and biophysical approaches.
© 2018 The Protein Society.

Entities:  

Keywords:  DNA binding domain; co-regulator; ligand binding domain; nuclear receptor; transactivation; transrepression

Mesh:

Substances:

Year:  2018        PMID: 30109749      PMCID: PMC6201731          DOI: 10.1002/pro.3496

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  149 in total

Review 1.  Signalling through nuclear receptors.

Authors:  Jamshed R Tata
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

Review 2.  Transcriptional activation by nuclear receptors.

Authors:  Mari Luz Acevedo; W Lee Kraus
Journal:  Essays Biochem       Date:  2004       Impact factor: 8.000

Review 3.  Principles for modulation of the nuclear receptor superfamily.

Authors:  Hinrich Gronemeyer; Jan-Ake Gustafsson; Vincent Laudet
Journal:  Nat Rev Drug Discov       Date:  2004-11       Impact factor: 84.694

Review 4.  The steroid receptor superfamily: mechanisms of diversity.

Authors:  P J Fuller
Journal:  FASEB J       Date:  1991-12       Impact factor: 5.191

5.  Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA.

Authors:  B F Luisi; W X Xu; Z Otwinowski; L P Freedman; K R Yamamoto; P B Sigler
Journal:  Nature       Date:  1991-08-08       Impact factor: 49.962

6.  Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid.

Authors:  J P Renaud; N Rochel; M Ruff; V Vivat; P Chambon; H Gronemeyer; D Moras
Journal:  Nature       Date:  1995-12-14       Impact factor: 49.962

7.  A canonical structure for the ligand-binding domain of nuclear receptors.

Authors:  J M Wurtz; W Bourguet; J P Renaud; V Vivat; P Chambon; D Moras; H Gronemeyer
Journal:  Nat Struct Biol       Date:  1996-01

8.  Influence of a steroid receptor DNA-binding domain on transcriptional regulatory functions.

Authors:  J A Lefstin; J R Thomas; K R Yamamoto
Journal:  Genes Dev       Date:  1994-12-01       Impact factor: 11.361

Review 9.  Single-Particle Cryo-EM at Crystallographic Resolution.

Authors:  Yifan Cheng
Journal:  Cell       Date:  2015-04-23       Impact factor: 41.582

Review 10.  Glucocorticoid receptor control of transcription: precision and plasticity via allostery.

Authors:  Emily R Weikum; Matthew T Knuesel; Eric A Ortlund; Keith R Yamamoto
Journal:  Nat Rev Mol Cell Biol       Date:  2017-01-05       Impact factor: 94.444

View more
  74 in total

1.  Quantitative structural assessment of graded receptor agonism.

Authors:  Jinsai Shang; Richard Brust; Patrick R Griffin; Theodore M Kamenecka; Douglas J Kojetin
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-14       Impact factor: 11.205

2.  Development of a new class of liver receptor homolog-1 (LRH-1) agonists by photoredox conjugate addition.

Authors:  Jeffery L Cornelison; Michael L Cato; Alyssa M Johnson; Emma H D'Agostino; Diana Melchers; Anamika B Patel; Suzanne G Mays; René Houtman; Eric A Ortlund; Nathan T Jui
Journal:  Bioorg Med Chem Lett       Date:  2020-05-30       Impact factor: 2.823

3.  Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator-activated receptor α.

Authors:  Darren M Gordon; Kari L Neifer; Abdul-Rizaq Ali Hamoud; Charles F Hawk; Andrea L Nestor-Kalinoski; Scott A Miruzzi; Michael P Morran; Samuel O Adeosun; Jeffrey G Sarver; Paul W Erhardt; Robert E McCullumsmith; David E Stec; Terry D Hinds
Journal:  J Biol Chem       Date:  2020-05-13       Impact factor: 5.157

Review 4.  Role of the glucocorticoid receptor in glomerular disease.

Authors:  Julie E Goodwin
Journal:  Am J Physiol Renal Physiol       Date:  2019-06-05

5.  Disruption of a key ligand-H-bond network drives dissociative properties in vamorolone for Duchenne muscular dystrophy treatment.

Authors:  Xu Liu; Yashuo Wang; Jennifer S Gutierrez; Jesse M Damsker; Kanneboyina Nagaraju; Eric P Hoffman; Eric A Ortlund
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-11       Impact factor: 11.205

Review 6.  Mechanisms of action of agrochemicals acting as endocrine disrupting chemicals.

Authors:  Genoa R Warner; Vasiliki E Mourikes; Alison M Neff; Emily Brehm; Jodi A Flaws
Journal:  Mol Cell Endocrinol       Date:  2019-12-12       Impact factor: 4.102

Review 7.  Nuclear receptors linking physiology and germline stem cells in Drosophila.

Authors:  Danielle S Finger; Kaitlin M Whitehead; Daniel N Phipps; Elizabeth T Ables
Journal:  Vitam Horm       Date:  2021       Impact factor: 3.421

Review 8.  Peroxisome Proliferator-Activated Receptor-Gamma (PPAR-ɣ): Molecular Effects and Its Importance as a Novel Therapeutic Target for Cerebral Ischemic Injury.

Authors:  Ashi Mannan; Nikhil Garg; Thakur Gurjeet Singh; Harmeet Kaur Kang
Journal:  Neurochem Res       Date:  2021-07-20       Impact factor: 3.996

9.  Significant association of LXRβ (NR1H2) polymorphisms (rs28514894, rs2303044) with type 2 diabetes mellitus and laboratory characteristics.

Authors:  Mohammad Bagher Sadeghi; Alireza Nakhaee; Ramin Saravani; Saman Sargazi
Journal:  J Diabetes Metab Disord       Date:  2021-01-27

Review 10.  Peroxisome proliferator-activated receptor gamma: a novel therapeutic target for cognitive impairment and mood disorders that functions via the regulation of adult neurogenesis.

Authors:  Juhee Lim; Hyo In Kim; Yeojin Bang; Hyun Jin Choi
Journal:  Arch Pharm Res       Date:  2021-06-17       Impact factor: 4.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.